Summary
Latest filing:
Derek Dirocco files SEC Form 4 reports at Acrivon Therapeutics, Inc. (ACRV). 4 SEC Form 4 filings on record going back to 2025, most recently on 22 June 2026.
Recent transactions
2The latest 2 SEC Form 4 transactions reported by Derek Dirocco.
Trading pattern
InsiderAlpha's records for Derek Dirocco go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Derek Dirocco files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Taylor Slingsby - $46.36M in MLYS purchases and sales in the last 12 months
- Jon Congleton - $15.64M in MLYS purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $8.76M in MLYS purchases and sales in the last 12 months
- Adam Scott Levy - $5.36M in MLYS purchases and sales in the last 12 months
- David Malcom Rodman - $4.43M in MLYS purchases and sales in the last 12 months
- Eric Warren - $3.30M in MLYS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Derek Dirocco?
Derek Dirocco is a corporate insider of Acrivon Therapeutics, Inc. (ACRV). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Derek Dirocco last file a Form 4?
The most recent primary Form 4 on record is dated 22 June 2026, one of 4 filings going back to 2025.